Table 1. Epidemiological profile of the case group (prostatic cancer) and control group.

	Cases	Controls	p
Metabolic syndrome	11 (68.7%)	4 (25.0%)	0.034*
Diabetes mellitus type 2	5 (15.6%)	1 (3.12%)	0.172
Dyslipidemia	4 (12.5%)	7 (21.8%)	0.458
Systemic arterial hypertension	13 (40.62%)	6 (18.7%)	0.029*
Family history of cancer	4 (12.5%)	7 (21.85%)	0.458
Family history of cardiovascular disease	6 (18.7%)	4 (12.5%)	0.704

^*statistical significance (p < 0.05).